The Institute for Clinical and Economic Review (ICER) has posted a revised Evidence Report assessing the comparative clinical ...

Cystic fibrosis (CF) specialist Sionna Therapeutics (Nasdaq: SION) has announced the appointment of Caroline Stark Beer as ...

Privately-held Dutch firm Scenic Biotech today announced the appointment of Roland Bürli as chief scientific officer (CSO), ...

Eli Lilly has announced positive topline results from the Phase III BRUIN CLL-313 trial of Jaypirca (pirtobrutinib), sending ...

The US Food and Drug Administration (FDA) yesterday issued two final guidances for industry related to biosimilar development ...

Saol Therapeutics has been dealt a blow in its effort to bring SL1009, an oral solution of sodium dichloroacetate (DCA), to ...

As Novartis continues its search for bolt-on products, the Swiss pharma giant today today revealed a deal to expand its ...

US clinical-stage biotech Rapport Therapeutics saw its shares close up 120% at $31.47 yesterday, after it announced that the ...

The settlement ends a case brought in 2024 under the Biologics Price Competition and Innovation Act. Enzeevu, approved by the ...

Arena BioWorks has named Harvey Berger as its new chief executive officer, according to an announcement on Monday. Mr Berger, ...

India's Ministry of Health has proposed amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, aimed at ...

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder that affects approximately 1 in 10,000 live ...